Role of bioincompatibility in dialysis morbidity and mortality (Q40646782)

22 September 2017

1 reference

title

Role of bioincompatibility in dialysis morbidity and mortality (English)

1 reference

22 September 2017

0 references

Lazarus JM

1

1 reference

22 September 2017

Owen WF

series ordinal

2

1 reference

22 September 2017

publication date

1 December 1994

1 reference

American Journal of Kidney Diseases

22 September 2017

published in

1 reference

22 September 2017

volume

24

1 reference

22 September 2017

issue

6

1 reference

22 September 2017

page(s)

1019-1032

1 reference

Definition of biocompatibility

22 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Severe anaphylactoid reactions to cuprammonium cellulose hemodialyzers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Acute anaphylactoid reactions in hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

First-use syndrome with cuprammonium cellulose dialyzers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Biocompatibility of artificial organs: an overview

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Stimulation of muscle protein degradation and prostaglandin E2 release by leukocytic pyrogen (interleukin-1). A mechanism for the increased degradation of muscle proteins during fever

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Nutritional aspects of leukocytic cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Migration of a Phthalate Ester Plasticizer from Polyvinyl Chloride Blood Bags into Stored Human Blood and Its Localization in Human Tissues

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

On the Exudation of Plasticizers from PVC Haemodialysis Tubings

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Migration of plasticizer from hemodialysis blood tubing. Preliminary report

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Plasticizers in P.V.C. and the Occurence of Hefatitis in A Haemodialysis Unit: A Preliminary Communication

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Spallation and migration of silicone from blood-pump tubing in patients on hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

IgE against ethylene oxide-altered human serum albumin in patients who have had acute dialysis reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Ethylene oxide (ETO) as a possible cause of an allergic reaction during peritoneal dialysis and immunologic detection of ETO from dialysis tubing

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Anaphylactoid reactions in dialysis patients: role of ethylene-oxide

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Hypersensitivity reactions during haemodialysis: role of complement fragments and ethylene oxide antibodies

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Eosinophilia and pulmonary dysfunction during Cuprophan hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Anaphylactoid reactions during hemodialysis on AN69 membranes in patients receiving ACE inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Anaphylactoid reactions during hemodialysis and hemofiltration: role of associating AN69 membrane and angiotensin I-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Relationship between dialyzer reuse and the presence of anti-N-like antibodies in chronic hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Successful production of sterile pyrogen-free electrolyte solution by ultrafiltration

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Host defenses and immunologic alterations associated with chronic hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Profound Neutropenia During the Early Phase of Hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Host immune status in uraemia. VI. Leucocytic response to bacterial infection in chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Neutrophil and monocyte alterations in chronic dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Granulocyte Adherence Changes Induced by Hemodialysis, Endotoxin, Epinephrine, and Glucocorticoids

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Increased expression of an adhesion-promoting surface glycoprotein in the granulocytopenia of hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Modulation of granulocyte LAM-1 and MAC-1 during dialysis--a prospective, randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Plasma levels of granulocyte elastase during hemodialysis: effects of different dialyzer membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo and in vitro within microamounts of whole blood

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Uremic serum effects on peripheral blood mononuclear cell and purified T lymphocyte responses

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

The humoral responses of haemodialysis patients to antigen challenge

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Suppressor cells in end-stage renal disease. Functional assays and monoclonal antibody analysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

T cell subsets and cellular immunity in end-stage renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Deficiency of T and B Lymphocytes in Uremic Subjects and Partial Improvement with Maintenance Hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Functional changes of monocytes due to dialysis membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Normal T lymphocyte function in patients with end-stage renal disease hemodialyzed with 'high-flux' polysulfone membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Complement and leukocyte-mediated pulmonary dysfunction in hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Complement Activation and Hypersensitivity Reactions to Dialysis Membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Analysis of the complement C3 fragments associated with hemodialysis membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Adsorption of unactivated complement proteins by hemodialysis membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Activation of complement by hemodialysis membranes: polyacrylonitrile binds more C3a than cuprophan

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Dialysis leukopenia, hypoxemia, and anaphylatoxin formation: effect of membrane, bath, and citrate anticoagulation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Heparin free hemodialysis does not cause fibrin consumptive coagulopathy and maintains alternate pathway complement activation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Effects of complement activation by hemodialysis membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Leukopenia, hypoxia, and complement function with different hemodialysis membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Hemodialysis-associated neutropenia and hypoxemia: the effect of dialyzer membrane materials

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Hemodialysis leukopenia and complement function with different dialyzers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Anaphylatoxin formation during hemodialysis: effects of different dialyzer membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Biocompatibility of dialysis membranes: Effects of chronic complement activation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Biocompatibility aspects of cellophane, cellulose acetate, polyacrylonitrile, polysulfone and polycarbonate hemodialyzers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

1 reference

7 January 2021

The polycarbonate hemodialysis membrane: neutrophil, platelet, complement and chemiluminescence kinetics during first and second use

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Enhanced biocompatibility with a new cellulosic membrane: Cuprophan versus Hemophan

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Anaphylatoxin formation during hemodialysis: comparison of new and re-used dialyzers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

A survey on hypersensitivity reactions in hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Celiac disease and schizophrenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Haemodialyser reuse: impact on function and biocompatibility

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Arterial Oxygenation during Hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Hypopnea associated with acetate hemodialysis: carbon dioxide-flow-dependent ventilation

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Hypoxemia during hemodialysis: effects of different membranes and dialysate compositions

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

The mechanisms of arterial hypoxemia during hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Dialysis hypoxemia. Role of dialyzer membrane and dialysate delivery system

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Hypoxemia during hemodialysis: a critical review of the facts

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Effects of acetate and bicarbonate hemodialysis on cardiac function in chronic dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Acetate-induced myocardial depression during hemodialysis for acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Less Dialysis-Induced Morbidity and Vascular Instability with Bicarbonate in Dialysate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

High sodium bicarbonate and acetate hemodialysis: Double-blind crossover comparison of hemodynamic and ventilatory effects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Interleukin-1: biology, pathophysiology, and clinical prospects

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Cytokines: agents provocateurs in hemodialysis?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Influence of uremia and hemodialysis on circulating interleukin-1 and tumor necrosis factor alpha

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

The effect of membrane characteristics on tumour necrosis factor kinetics during haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Blood-membrane interaction in hemodialysis leads to increased cytokine production

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Effect of renal replacement therapy on cellular cytokine production in patients with renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

In vivo T cell preactivation in chronic uremic hemodialyzed and non-hemodialyzed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Hemodialysis with cuprophane membrane modulates interleukin-2 receptor expression

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Elevated circulating levels of interleukin-6 in patients with chronic renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

In vitro interleukin-1 production by different dialysis membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

In vivo induction of interleukin-1 during hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Hemodialysis-associated induction of cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

In vitro production of interleukin-1 receptor antagonist in chronic renal failure, CAPD and HD

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

The role of dialysate in the stimulation of interleukin-1 production during clinical hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

In vitro study of the transfer of cytokine-inducing substances across selected high-flux hemodialysis membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Permeability of dialyzer membranes to TNF alpha-inducing substances derived from water bacteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Enhancement of in-vitro human interleukin-1 production by sodium acetate

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Effects of acetate dialysate on transforming growth factor β1, interleukin, and β2-microglobulin plasma levels

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Carpal tunnel syndrome in patients on intermittent haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Deposition of an amyloid-like substance as a possible complication of regular dialysis treatment

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Destructive spondylarthropathy in hemodialyzed patients. A new syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Erosive azotemic osteoarthropathy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Amyloid arthropathy in patients undergoing periodical haemodialysis for chronic renal failure: a new complication

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Carpal tunnel syndrome with cystic bone lesions secondary to amyloidosis in chronic hemodialysis patients.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Gastrointestinal complications of dialysis related amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Amyloid kidney stones of uremic patients consist of beta 2-microglobulin fragments

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Appearance of systemic amyloidosis in a chronic hemodialysis patient

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

A new form of amyloid protein associated with chronic hemodialysis was identified as beta 2-microglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Beta-2 microglobulin is an amyloidogenic protein in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

In vitro formation of amyloid fibrils from intact beta 2-microglobulin

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Plasma β2, Microglobulin Turnover in Renal Insufficiency

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Evaluation of beta 2-microglobulin removal with high-performance hemodiafiltration

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Removal, generation and adsorption of beta-2-microglobulin during hemofiltration with five different membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Long-term variations of serum beta 2-microglobulin levels in hemodialysed uremics according to permeability and bioincompatibility of dialysis membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Beta-2-microglobulin synthesis is increased during activation of human monocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Beta-2-microglobulin in hemodialysis patients. Effects of different dialyzers and different dialysis procedures

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Effects of dialysis membranes on beta 2-microglobulin production and cellular expression

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Kinetics of 125I-beta 2-microglobulin turnover in dialyzed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Which membrane? Should beta-2-microglobulin decide on the choice of today's hemodialysis membrane?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Case control study on dialysis arthropathy: the influence of two different dialysis membranes: data from the EDTA Registry

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Effect of dialysis membrane and patient's age on signs of dialysis-related amyloidosis. The Working Party on Dialysis Amyloidosis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Beta 2-microglobulin kinetics in maintenance hemodialysis: a comparison of conventional and high-flux dialyzers and the effects of dialyzer reuse

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

The effects of reprocessing cuprophane and polysulfone dialyzers on beta 2-microglobulin removal from hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Clearance of beta-2-microglobulin using continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Beta 2-microglobulin amyloidosis in a patient treated exclusively by continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Cuprammonium membranes stimulate interleukin 1 release and arachidonic acid metabolism in monocytes in the absence of complement

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Synthesis of thromboxane B2 in uraemia and the effects of dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

The role of thromboxane in cuprophan-induced pulmonary hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

A simple in vitro test to evaluate biocompatibility of dialysis membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Leukotriene B4 in hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

1 reference

7 January 2021

Hemostatic abnormalities in renal disease

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Platelet dysfunction in uremia. Multifaceted defect partially corrected by dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Hemodialysis-associated platelet activation and thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Alterations in hemostatic parameters during hemodialysis with dialyzers of different membrane composition and flow design. Platelet activation and factor VIII-related von Willebrand factor during hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Isolation and partial characterization of platelet aggregation inhibitors in the blood of dialyzed patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Heparin-associated thrombocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Effects of hemodialysis and peritoneal dialysis on antithrombin III and platelets

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Antithrombin-III and Platelets in Haemodialysis Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Factor VIII complex in uraemia and effects of haemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Effect of hemodialysis on contact group of coagulation factors, platelets, and leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Enhanced fibrinolysis caused by tissue plasminogen activator release in hemodialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Aspects of biocompatibility of two different dialysis membranes: cuprophane and polysulfone

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Activation of platelets, coagulation and fibrinolysis in patients on long-term haemodialysis: influence of cuprophan and polyacrylonitrile membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

Evaluation of Platelets and Hemostasis during Hemodialysis with Six Different Membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2981077-8

7 January 2021

10.1016/S0272-6386(12)81077-8

Identifiers

DOI

1 reference

22 September 2017

1 reference